TIGIT 阻断通过增加 TCR 信号强度,挽救了低亲和力 TCR 工程化 T 细胞的抗肿瘤活性
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.
T细胞亲和力是过继性T细胞疗法(ACT)治疗癌症疗效的主要决定因素。
76.4分
★★★★☆
ALL SOURCES
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.
T细胞亲和力是过继性T细胞疗法(ACT)治疗癌症疗效的主要决定因素。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。